logo
  

Enlivex Reports Initiation Of Dosing In Phase IIb Trial With Allocetra - Quick Facts

Enlivex Therapeutics Ltd. (ENLV) announced the initiation of dosing in its placebo-controlled phase IIb trial evaluating Allocetra in severe and critical COVID-19 patients with acute respiratory distress syndrome. The trial is expected to recruit up to 152 severe COVID-19 patients in clinical centers in Israel and certain European countries. Top-line data are anticipated in the second quarter of 2022.

Enlivex previously reported positive top-line results from phase Ib and phase II investigator-initiated clinical trials of Allocetra in COVID-19 patients in severe and critical condition.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Alexander & Hornung, a business unit of Perdue Premium Meat Co., Inc., is recalling around 234,391 pounds of fully cooked pork products citing possible contamination with Listeria monocytogenes, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves ham and pepperoni products that come under various brands and produced on various dates. Sandoz, Inc., an unit of Novartis AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high temperatures that may have impacted product effectiveness, the U.S. Food and Drug Administration or FDA said in a statement. Livia Global, Inc., a health and wellness company, is recalling two lots of its Liviaone liquid probiotics citing the possibility of contamination by Pseudomonas aeruginosa, the U.S. Food and Drug Administration said. Pseudomonas aeruginosa is a microorganism found in the environment that, if ingested, can cause life-threatening infection in immunocompromised individuals.
RELATED NEWS
Follow RTT